{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:11:41Z","timestamp":1760548301691,"version":"3.32.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ijrobp.2006.02.029","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T02:55:54Z","timestamp":1149648954000},"page":"982-989","source":"Crossref","is-referenced-by-count":25,"title":["Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy"],"prefix":"10.1016","volume":"65","author":[{"given":"Geoffrey S.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan B.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian R.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grahame C.W.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.02.029_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib2","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2000.18.14.2740","article-title":"Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials","volume":"18","author":"Valicenti","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(03)00752-1","article-title":"Hypofractionated conformal radiotherapy in carcinoma of the prostate","volume":"57","author":"Livsey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib4","series-title":"The 2005 Multidisciplinary Prosate Cancer Symposium Program\/Proceedings","first-page":"78","article-title":"Randomized pilot study of conventional or hypofractionated high dose intensity modulated prostate radiotherapy (CHHIP)\u2014acute toxicity report","author":"Khoo","year":"2005"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib5","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomised trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1464-410X.1992.tb15601.x","article-title":"Hormonal cytoreduction and radiotherapy for carcinoma of the prostate","volume":"69","author":"Shearer","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/07357909509024889","article-title":"Neoadjuvant hormonal downsizing of localised carcinoma of the prostate","volume":"13","author":"Forman","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0360-3016(97)00309-X","article-title":"Androgen deprivation and radiation therapy","volume":"38","author":"Zietman","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.ju.0000112979.97941.7f","article-title":"The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2\u2013T3 prostate cancer","volume":"171","author":"Laverdiere","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib11","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2003.05.004","article-title":"Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression","volume":"21","author":"Roach","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Supll. 1","key":"10.1016\/j.ijrobp.2006.02.029_bib12","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ijrobp.2005.07.038","article-title":"An update of the Phase III trial comparing whole-pelvic (WP) to prostate-only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS)","volume":"63","author":"Lawton","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(05)70348-X","article-title":"Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer","volume":"6","author":"Denham","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0360-3016(03)00439-5","article-title":"Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias","volume":"57","author":"Pickles","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2003.08.009","article-title":"Ambiguities within the ASTRO consensus definition of biochemical failure","volume":"58","author":"Williams","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0360-3016(02)02707-4","article-title":"Practical applications of biochemical failure definitions","volume":"53","author":"Kestin","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Non-parametric estimation from incomplete samples","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part II. Analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc (B)"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib20","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X","article-title":"Prognostic factors for clinically localized prostate carcinoma","volume":"79","author":"Zagars","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib21","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/cncr.10919","article-title":"An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up","volume":"95","author":"Vicini","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib22","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2154::AID-CNCR13>3.0.CO;2-V","article-title":"An enhanced prognostic system for clinically localized carcinoma of the prostate","volume":"79","author":"Pisansky","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0360-3016(03)00820-4","article-title":"What defines intermediate-risk prostate cancer? Variability in published prognostic models","volume":"58","author":"Williams","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0360-3016(01)01466-3","article-title":"Radiation does response in patients with favourable localized prostate cancer","volume":"50","author":"Kupelian","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0360-3016(03)00630-8","article-title":"Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy","volume":"57","author":"Kupelian","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/dji248","article-title":"Prostate cancer and the Will Rogers Phenomenon","volume":"97","author":"Albertsen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1464-410x.2000.00380.x","article-title":"The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate","volume":"85","author":"Heung","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0090-4295(97)00016-2","article-title":"Transrectal ultrasound-guided biopsy causes haematogenous dissemination of prostate cells as determined by RT-PCR","volume":"49","author":"Moreno","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-5347(17)38745-1","article-title":"The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localised prostate cancer","volume":"142","author":"Meacham","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-5347(05)64652-6","article-title":"Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer","volume":"168","author":"See","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1464-410X.2003.04026.x","article-title":"The role of antiandrogen monotherapy in the treatment of prostate cancer","volume":"91","author":"Anderson","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1464-410X.1995.tb07229.x","article-title":"Radical radiotherapy for localized adenocarcinoma of the prostate","volume":"75","author":"El-Galley","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is \u03b1\/\u03b2 for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0360-3016(03)01455-X","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"57","author":"Kal","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0360-3016(00)00442-9","article-title":"Is the prostate \u03b1\/\u03b2 ratio of 1.5 from Brenner & Hall a modelling artefact?","volume":"47","author":"King","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib38","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1088\/0031-9155\/49\/19\/003","article-title":"Comparison of in vitro and in vivo \u03b1\/\u03b2 ratios for prostate cancer","volume":"49","author":"Carlson","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2004.12.019","article-title":"Is the alpha-beta ratio of prostate cancer really low? A prospective non-randomised trial comparing standard and hyperfractionated conformal radiotherapy","volume":"75","author":"Valdagni","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib40","series-title":"Basic clinical radiobiology","first-page":"120","article-title":"Time-dose relationships","author":"Joiner","year":"2002"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib41","unstructured":"Government Actuary\u2019s Department. http:\/\/www.statistics.gov.uk\/cci\/nugget.asp?id=918."},{"key":"10.1016\/j.ijrobp.2006.02.029_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0090-4295(99)00380-5","article-title":"Importance of high radiation doses (72Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate","volume":"55","author":"Lyons","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(00)00620-9","article-title":"External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era","volume":"48","author":"Pollack","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.02.029_bib44","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate","volume":"21","author":"Hanks","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:48:16Z","timestamp":1736405296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0360301606003865"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.029","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}